7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative

PH12021551957B1Active Publication Date: 2026-09-30TAIHO PHARMA CO LTD

0 Cites 0 Cited by

Patent Information

Application Number: PH12021551957
Authority / Receiving Office: PH · PH
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2021-08-12
Publication Date: 2026-09-30
Estimated Expiration: 2041-08-12

Application Information

Patent Timeline

12 Aug 2021

Application

PH12021551957

30 Sep 2026

Publication

PH12021551957B1

Inventors: YAMAMOTO Fuyuki; MIZUTANI Takashi

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention provides a novel compound inhibiting EGFR or a salt of the compound. According to one embodiment of the present invention, provided is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof.

Need to check novelty before this filing date? Find Prior Art